Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
147M
-
Number of holders
-
1087
-
Total 13F shares, excl. options
-
178M
-
Shares change
-
-8.54M
-
Total reported value, excl. options
-
$51.7B
-
Value change
-
-$2.44B
-
Put/Call ratio
-
1.51
-
Number of buys
-
481
-
Number of sells
-
-484
-
Price
-
$290.24
Significant Holders of BIOGEN INC. - COM (BIIB) as of Q2 2018
1,220 filings reported holding BIIB - BIOGEN INC. - COM as of Q2 2018.
BIOGEN INC. - COM (BIIB) has 1,087 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 178M shares
.
Largest 10 shareholders include BlackRock Inc. (17.1M shares), VANGUARD GROUP INC (15.3M shares), PRIMECAP MANAGEMENT CO/CA/ (14.9M shares), Clearbridge Investments, LLC (9.53M shares), STATE STREET CORP (8.9M shares), FMR LLC (5.35M shares), WELLINGTON MANAGEMENT GROUP LLP (5.06M shares), Invesco Ltd. (3.86M shares), ALLIANCEBERNSTEIN L.P. (3.83M shares), and NORTHERN TRUST CORP (2.89M shares).
This table shows the top 1087 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.